Keywords: entremed, gets, go-ahead, phase, trial, angiostatin, food

EntreMed gets US go-ahead for Phase I trial of angiostatin

Article | 03 February 2000

Print This

The US Food and Drug Administration has approved a Phase Idose-escalating human trial of EntreMed's experimental cancer drug angiostatin, and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in